carvedilol has been researched along with Hypotension in 22 studies
Hypotension: Abnormally low BLOOD PRESSURE that can result in inadequate blood flow to the brain and other vital organs. Common symptom is DIZZINESS but greater negative impacts on the body occur when there is prolonged depravation of oxygen and nutrients.
Excerpt | Relevance | Reference |
---|---|---|
"Data were retrospectively collected from 23 patients with HF [age 57±18 years, left ventricular ejection fraction (LVEF) 33±15%] who could not increase the dosage of carvedilol because of dizziness or hypotension, defined as systolic blood pressure<90 mmHg." | 7.79 | Switching from carvedilol to bisoprolol ameliorates adverse effects in heart failure patients with dizziness or hypotension. ( Asano, Y; Ichibori, Y; Kanzaki, M; Komuro, I; Minamiguchi, H; Mizote, I; Ohtani, T; Sakata, Y; Taniguchi, T, 2013) |
"A 54-year-old white man with severe heart failure was placed on carvedilol 3." | 7.70 | Hypotension with dobutamine: beta-adrenergic antagonist selectivity at low doses of carvedilol. ( Bristow, MR; Lindenfeld, J; Lowes, BD, 1999) |
"beta-blockers (BB) in the treatment of heart failure (HF) are frequently underprescribed and underdosed, perhaps because of recommendations for office visits at each dose change." | 5.32 | Remote titration of carvedilol for heart failure patients by advanced practice nurses. ( Mischke, L; Moyer-Knox, D; Mueller, TM; Vuckovic, K; Williams, RE, 2004) |
"Data were retrospectively collected from 23 patients with HF [age 57±18 years, left ventricular ejection fraction (LVEF) 33±15%] who could not increase the dosage of carvedilol because of dizziness or hypotension, defined as systolic blood pressure<90 mmHg." | 3.79 | Switching from carvedilol to bisoprolol ameliorates adverse effects in heart failure patients with dizziness or hypotension. ( Asano, Y; Ichibori, Y; Kanzaki, M; Komuro, I; Minamiguchi, H; Mizote, I; Ohtani, T; Sakata, Y; Taniguchi, T, 2013) |
"A 54-year-old white man with severe heart failure was placed on carvedilol 3." | 3.70 | Hypotension with dobutamine: beta-adrenergic antagonist selectivity at low doses of carvedilol. ( Bristow, MR; Lindenfeld, J; Lowes, BD, 1999) |
"Beta-blockers substantially improve survival in patients with chronic heart failure (HF) with left ventricular systolic dysfunction, but concerns about cardiovascular adverse effects may deter physicians from prescribing this therapy." | 2.71 | Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of randomized trials. ( Coffey, CS; Curtis, JP; Foody, JM; Hebert, PR; Ko, DT; Krumholz, HM; Sedrakyan, A, 2004) |
"Flushing and erythema are frequent skin symptoms in rosacea." | 2.66 | Use of beta-blockers for rosacea-associated facial erythema and flushing: A systematic review and update on proposed mode of action. ( Driessen, RJB; Logger, JGM; Olydam, JI, 2020) |
" Beta-blocker dosages were titrated, and three patients achieved the target beta-blocker dosage established for stage A-C heart failure." | 1.34 | Tolerability of beta-blockers in outpatients with refractory heart failure who were receiving continuous milrinone. ( Earl, GL; Fitzpatrick, JM; Narula, J; Verbos-Kazanas, MA, 2007) |
"beta-blockers (BB) in the treatment of heart failure (HF) are frequently underprescribed and underdosed, perhaps because of recommendations for office visits at each dose change." | 1.32 | Remote titration of carvedilol for heart failure patients by advanced practice nurses. ( Mischke, L; Moyer-Knox, D; Mueller, TM; Vuckovic, K; Williams, RE, 2004) |
"Carvedilol is a non selective beta-adrenoceptor antagonist which also causes peripheral vasodilation primarily via alpha 1-adrenergic blockade (Strein et al." | 1.30 | Carvedilol overdose. ( Hantson, P; Lambermont, JY; Mahieu, P; Simoens, G, 1997) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (18.18) | 18.2507 |
2000's | 9 (40.91) | 29.6817 |
2010's | 6 (27.27) | 24.3611 |
2020's | 3 (13.64) | 2.80 |
Authors | Studies |
---|---|
Groszek, G | 1 |
Bednarski, M | 1 |
Dybała, M | 1 |
Filipek, B | 1 |
Nadal, MÁ | 1 |
Viera Ramírez, ER | 1 |
García Vallejo, M | 1 |
Martín Capón, I | 1 |
Fernández Lucas, M | 1 |
Stone, KH | 1 |
Reynolds, K | 1 |
Davis, S | 1 |
Van Tassell, BW | 1 |
Gibson, CM | 1 |
Logger, JGM | 1 |
Olydam, JI | 1 |
Driessen, RJB | 1 |
Taniguchi, T | 1 |
Ohtani, T | 1 |
Mizote, I | 1 |
Kanzaki, M | 1 |
Ichibori, Y | 1 |
Minamiguchi, H | 1 |
Asano, Y | 1 |
Sakata, Y | 1 |
Komuro, I | 1 |
Nakamura, K | 1 |
Fukami, N | 1 |
Nabeta, T | 1 |
Inomata, T | 1 |
Iida, Y | 1 |
Ikeda, Y | 1 |
Iwamoto-Ishida, M | 1 |
Ishii, S | 1 |
Naruke, T | 1 |
Mizutani, T | 1 |
Shinagawa, H | 1 |
Koitabashi, T | 1 |
Takeuchi, I | 1 |
Ako, J | 1 |
Steib, CJ | 1 |
Gerbes, AL | 1 |
Forrester, MB | 1 |
Nabbi, R | 1 |
Riess, ML | 1 |
Woehlck, HJ | 1 |
Cohen-Solal, A | 1 |
Logeart, D | 1 |
Guiti, C | 1 |
Bourgoin, P | 1 |
Watanabe, K | 1 |
Abe, Y | 1 |
Sato, S | 1 |
Wahed, M | 1 |
Wen, J | 1 |
Narasimman, G | 1 |
Ma, M | 1 |
Ali, F | 1 |
Saito, Y | 1 |
Suresh, P | 1 |
Shirai, K | 1 |
Soga, M | 1 |
Nagai, Y | 1 |
Takahashi, T | 1 |
Hasegawa, G | 1 |
Naito, M | 1 |
Tachikawa, H | 1 |
Tanabe, N | 1 |
Kodama, M | 1 |
Aizawa, Y | 1 |
Yamaguchi, K | 1 |
Miyazaki, M | 1 |
Kakemi, M | 1 |
Moyer-Knox, D | 1 |
Mueller, TM | 1 |
Vuckovic, K | 1 |
Mischke, L | 1 |
Williams, RE | 1 |
Ko, DT | 1 |
Hebert, PR | 1 |
Coffey, CS | 1 |
Curtis, JP | 1 |
Foody, JM | 1 |
Sedrakyan, A | 1 |
Krumholz, HM | 1 |
Earl, GL | 1 |
Verbos-Kazanas, MA | 1 |
Fitzpatrick, JM | 1 |
Narula, J | 1 |
Vural, M | 1 |
Fett, JD | 1 |
Hantson, P | 1 |
Lambermont, JY | 1 |
Simoens, G | 1 |
Mahieu, P | 1 |
Cleophas, TJ | 1 |
van der Meulen, J | 1 |
van de Luit, L | 1 |
Zwinderman, AH | 1 |
Lindenfeld, J | 1 |
Lowes, BD | 1 |
Bristow, MR | 1 |
Forrest, E | 1 |
Stanley, A | 1 |
Hayes, P | 1 |
1 review available for carvedilol and Hypotension
Article | Year |
---|---|
Use of beta-blockers for rosacea-associated facial erythema and flushing: A systematic review and update on proposed mode of action.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Bradycardia; Carvedilol; Dermatologic Agents; Dru | 2020 |
2 trials available for carvedilol and Hypotension
Article | Year |
---|---|
Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of randomized trials.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Bradycardia; Carbazoles; Carvedilol; Dizziness; Fatig | 2004 |
Daytime-selective antihypertensive activity of celiprolol.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Amlodipine; Angiotensin-Converting Enzyme | 1999 |
19 other studies available for carvedilol and Hypotension
Article | Year |
---|---|
Synthesis and adrenolytic activity of 1-(1H-indol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}propan-2-ol and its enantiomers. Part 1.
Topics: 2-Propanol; Adrenergic Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electroca | 2009 |
Effect of Beta-Blocker Cardioselectivity on Vascular Refilling in Hemodialysis Patients.
Topics: Adrenergic beta-Antagonists; Carvedilol; Cross-Over Studies; Humans; Hypotension; Prospective Studie | 2021 |
Comparison of new-onset post-operative atrial fibrillation between patients receiving carvedilol and metoprolol after off-pump coronary artery bypass graft surgery.
Topics: Adrenergic beta-Antagonists; Adult; Atrial Fibrillation; Bradycardia; Carvedilol; Coronary Artery By | 2023 |
Switching from carvedilol to bisoprolol ameliorates adverse effects in heart failure patients with dizziness or hypotension.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Dizziness; Dose-Response Rela | 2013 |
Altered responses to vasopressors of a patient medicated with carvedilol, pilsicainide and enalapril.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Atria | 2014 |
Prognostic significance of beta-blocker up-titration in conjunction with cardiac resynchronization therapy in heart failure management.
Topics: Adrenergic beta-Antagonists; Aged; Blood Pressure; Bradycardia; Carbazoles; Cardiac Resynchronizatio | 2016 |
Secondary prophylaxis for variceal bleeding: carvedilol vs. propranolol.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Carbazoles; Carvedilol; Drug Monitoring; Esophageal and | 2017 |
Pediatric carvedilol ingestions reported to Texas poison centers, 2000 to 2008.
Topics: Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Child, Preschool; Combined Modality Therapy; Fe | 2010 |
Angiotensin-receptor-blocker-induced refractory hypotension responds to methylene blue.
Topics: Aged; Angiotensin Receptor Antagonists; Carbazoles; Carvedilol; Citalopram; Crystalloid Solutions; D | 2012 |
[Use of carvedilol in daily practice].
Topics: Adrenergic beta-Antagonists; Bradycardia; Carbazoles; Cardiology; Carvedilol; Coronary Disease; Drug | 1999 |
Contribution of sympathetic nervous system activity during administration of carvedilol in rats with dilated cardiomyopathy.
Topics: Animals; Blood Pressure; Body Weight; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Dose-Response | 2003 |
Remote titration of carvedilol for heart failure patients by advanced practice nurses.
Topics: Adrenergic beta-Antagonists; Aged; Bradycardia; Carbazoles; Carvedilol; Clinical Protocols; Cohort S | 2004 |
Tolerability of beta-blockers in outpatients with refractory heart failure who were receiving continuous milrinone.
Topics: Adrenergic beta-Antagonists; Aged; Arrhythmias, Cardiac; Blood Pressure; Carbazoles; Cardiac Output, | 2007 |
[Role of the drug interaction between carvedilol and dobutamine in inducing of severe hypotension in a case with acute coronary syndrome].
Topics: Aged; Carbazoles; Cardiotonic Agents; Carvedilol; Diagnosis, Differential; Dobutamine; Drug Interact | 2007 |
Case 36-2007: a woman with rash, fever, and hypotension.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Carbazoles; Carvedilol; Female; Humans; Hypotensi | 2008 |
Carvedilol overdose.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Carbazoles; Carvedilol; Dopamine; Drug Overdose; Electr | 1997 |
Hypotension with dobutamine: beta-adrenergic antagonist selectivity at low doses of carvedilol.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Blood Pressure; Carbazoles; Cardiac Ou | 1999 |
Carvedilol--A new nonselective beta blocker.
Topics: Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Hemodynamics; Humans; Hypotension; Liver Cirrho | 2000 |
Beta-blockers for heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Bradycardia; Carbazoles; Carvedilol; Heart Failure; Humans; | 2000 |